Key result
Mutating Arg residues 331 and 332 in Sindbis virus nsP4 blocks subgenomic RNA promoter binding.
The study identifies specific arginine residues (331 and 332) in the Sindbis virus nsP4 protein that are essential for binding to the subgenomic RNA promoter.
Hypothesis-generating for alphavirus antivirals; requires validation in relevant models before any therapeutic consideration.
A gel mobility-shift assay was used to demonstrate the binding of the Sindbis virus transcriptase to the promoter for the synthesis of subgenomic (SG) RNA. The assay made use of a P15 fraction (the cell fraction that is pelleted at 15,000 x g) from cells infected with recombinant vaccinia virions expressing various Sindbis virus nonstructural proteins (nsPs) and a (32)P-labeled 24-mer oligoribonucleotide representing the minimal sequence with SG promoter activity. By itself, nsP4, the viral RNA-dependent RNA polymerase, did not bind to the SG promoter; rather, all four nsPs were required for the binding of the transcriptase to the promoter. UV crosslinking of the transcriptase to a thiouridine-containing SG promoter, followed by V8 protease digestion of the complex, generated a peptide fragment that was bound to the SG promoter. This peptide fragment contained a sequence that corresponded to residues 329-334 of nsP4. This peptide may be in the fingers domain of nsP4. The peptide that was identified contained Arg residues at positions 331 and 332. Another Arg is present at position 327. By changing each of the Arg residues to Ala, we demonstrated that only the Arg residues at positions 331 and 332 were required for binding nsP4 to the SG promoter.
No takes yet. Share an insight, caveat, or question.
Li et al. (2004) studied Sindbis virus infection (in vitro). Mutation of Arg residues to Ala in nsP4 vs. Wild-type nsP4 was evaluated on Binding of nsP4 to the subgenomic RNA promoter. Mutation of Arg residues to Ala demonstrated that Arg residues at positions 331 and 332 in the Sindbis virus nsP4 protein are required for binding to the subgenomic RNA promoter.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: